Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ)
CNY 3.29
(4.44%)
CNY 3.29
(4.44%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 506.63 Million CNY | -18.84% |
| 2022 | 624.24 Million CNY | -9.18% |
| 2021 | 687.31 Million CNY | 19.87% |
| 2020 | 573.39 Million CNY | 42.45% |
| 2019 | 402.52 Million CNY | 90.96% |
| 2018 | 210.79 Million CNY | -53.23% |
| 2017 | 450.72 Million CNY | -31.56% |
| 2016 | 658.53 Million CNY | 23.11% |
| 2015 | 534.9 Million CNY | 19.66% |
| 2014 | 447.01 Million CNY | 31.65% |
| 2013 | 339.53 Million CNY | 46.92% |
| 2012 | 231.09 Million CNY | 89.17% |
| 2011 | 122.16 Million CNY | 19.74% |
| 2010 | 102.02 Million CNY | 26.01% |
| 2009 | 80.96 Million CNY | 25.76% |
| 2008 | 64.38 Million CNY | 61.56% |
| 2007 | 39.85 Million CNY | 441.3% |
| 2006 | 7.36 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 20.12 Million CNY | -77.67% |
| 2024 Q2 | 90.11 Million CNY | 55.04% |
| 2024 Q1 | 58.12 Million CNY | 237.19% |
| 2023 Q3 | 163.3 Million CNY | -4.17% |
| 2023 FY | 506.63 Million CNY | -18.84% |
| 2023 Q1 | 175.45 Million CNY | 14.16% |
| 2023 Q2 | 170.42 Million CNY | -2.87% |
| 2023 Q4 | 17.23 Million CNY | -89.45% |
| 2022 Q2 | 113.96 Million CNY | -52.16% |
| 2022 Q1 | 238.23 Million CNY | 374.27% |
| 2022 Q3 | 118.28 Million CNY | 3.79% |
| 2022 FY | 624.24 Million CNY | -9.18% |
| 2022 Q4 | 153.68 Million CNY | 29.93% |
| 2021 Q4 | 50.23 Million CNY | -74.79% |
| 2021 Q3 | 199.23 Million CNY | -18.58% |
| 2021 Q1 | 193.16 Million CNY | 850.6% |
| 2021 Q2 | 244.69 Million CNY | 26.68% |
| 2021 FY | 687.31 Million CNY | 19.87% |
| 2020 Q1 | 109.32 Million CNY | 196.13% |
| 2020 Q3 | 255.35 Million CNY | 8.92% |
| 2020 Q4 | -25.73 Million CNY | -110.08% |
| 2020 FY | 573.39 Million CNY | 42.45% |
| 2020 Q2 | 234.44 Million CNY | 114.44% |
| 2019 Q1 | 175.34 Million CNY | 169.46% |
| 2019 Q4 | -113.73 Million CNY | -168.52% |
| 2019 Q3 | 165.97 Million CNY | -5.12% |
| 2019 Q2 | 174.93 Million CNY | -0.23% |
| 2019 FY | 402.52 Million CNY | 90.96% |
| 2018 Q2 | 178.73 Million CNY | 7.17% |
| 2018 FY | 210.79 Million CNY | -53.23% |
| 2018 Q4 | -252.43 Million CNY | -314.45% |
| 2018 Q3 | 117.71 Million CNY | -34.14% |
| 2018 Q1 | 166.78 Million CNY | 90718.19% |
| 2017 FY | 450.72 Million CNY | -31.56% |
| 2017 Q1 | 132.54 Million CNY | -27.31% |
| 2017 Q2 | 149.85 Million CNY | 13.06% |
| 2017 Q4 | -184.05 Thousand CNY | -100.11% |
| 2017 Q3 | 168.51 Million CNY | 12.45% |
| 2016 Q3 | 164.77 Million CNY | -11.54% |
| 2016 FY | 658.53 Million CNY | 23.11% |
| 2016 Q4 | 182.33 Million CNY | 10.66% |
| 2016 Q2 | 186.27 Million CNY | 48.84% |
| 2016 Q1 | 125.14 Million CNY | 18.07% |
| 2015 Q3 | 181.15 Million CNY | 13.52% |
| 2015 FY | 534.9 Million CNY | 19.66% |
| 2015 Q2 | 159.57 Million CNY | 80.99% |
| 2015 Q1 | 88.17 Million CNY | -21.44% |
| 2015 Q4 | 105.99 Million CNY | -41.49% |
| 2014 Q4 | 112.23 Million CNY | -1.82% |
| 2014 Q2 | 137.37 Million CNY | 65.32% |
| 2014 Q1 | 83.09 Million CNY | -3.61% |
| 2014 FY | 447.01 Million CNY | 31.65% |
| 2014 Q3 | 114.3 Million CNY | -16.79% |
| 2013 FY | 339.53 Million CNY | 46.92% |
| 2013 Q4 | 86.2 Million CNY | -2.25% |
| 2013 Q1 | 61.09 Million CNY | 10.79% |
| 2013 Q2 | 104.03 Million CNY | 70.28% |
| 2013 Q3 | 88.19 Million CNY | -15.23% |
| 2012 Q4 | 55.14 Million CNY | -19.14% |
| 2012 Q2 | 69.73 Million CNY | 83.46% |
| 2012 Q1 | 38.01 Million CNY | -8.5% |
| 2012 FY | 231.09 Million CNY | 89.17% |
| 2012 Q3 | 68.2 Million CNY | -2.2% |
| 2011 Q2 | 23.73 Million CNY | 22.27% |
| 2011 Q4 | 41.54 Million CNY | 10.83% |
| 2011 FY | 122.16 Million CNY | 19.74% |
| 2011 Q1 | 19.4 Million CNY | -48.22% |
| 2011 Q3 | 37.48 Million CNY | 57.96% |
| 2010 Q2 | 18.28 Million CNY | 30.66% |
| 2010 Q4 | 37.48 Million CNY | 16.18% |
| 2010 Q3 | 32.26 Million CNY | 76.4% |
| 2010 Q1 | 13.99 Million CNY | -50.43% |
| 2010 FY | 102.02 Million CNY | 26.01% |
| 2009 Q2 | 17.33 Million CNY | 67.34% |
| 2009 Q1 | 10.35 Million CNY | -65.27% |
| 2009 FY | 80.96 Million CNY | 25.76% |
| 2009 Q4 | 28.24 Million CNY | 12.78% |
| 2009 Q3 | 25.04 Million CNY | 44.48% |
| 2008 Q3 | 13.3 Million CNY | 0.0% |
| 2008 FY | 64.38 Million CNY | 61.56% |
| 2008 Q4 | 29.81 Million CNY | 124.19% |
| 2007 FY | 39.85 Million CNY | 441.3% |
| 2006 FY | 7.36 Million CNY | 0.0% |